 Table of 
Syntheses
General methods. Compounds 9 and 10 S1-S5 as well as 16 S6 and 21 S2 were prepared according to established procedures. All other chemicals were purchased from standard suppliers. Reactions involving oxygen and/or moisture sensitive reagents were carried out under an atmosphere of argon using anhydrous solvents. Anhydrous solvents were obtained in the following manner: THF was dried over sodium/benzophenone and distilled, CH 2 Cl 2 was dried over P 2 O 5 and distilled, MeOH was dried over activated molecular sieves (3 Å) and degassed, MeCN was dried over P 2 O 5 and distilled, DMF was dried over activated molecular sieves (4 Å) and degassed, i-PrOH was dried over activated molecular sieves (3 Å) and degassed. All other solvents were of technical quality and distilled prior to their use, and deionised water was used throughout. Column chromatography was carried out on silica gel 60 (0.040-0.063 mm, 230-400 mesh ASTM, VWR) under flash conditions. TLC was performed on aluminum plates precoated with silica gel 60 F 254 (VWR). Visualization of the spots was carried out using UV light (254 nm) and/or staining under heating (H 2 SO 4 staining solution: 4 g vanillin, 25 mL conc. H 2 SO 4 , 80 mL AcOH and 680 mL MeOH; KMnO 4 staining solution: 1 g KMnO 4 , 6 g K 2 CO 3 and 1.5 mL 1.25 M NaOH solution, all dissolved in 100 mL H 2 O; ninhydrin staining solution: 0.3 g ninhydrin, 3 mL AcOH and 100 mL 1-butanol). Analytical HPLC was performed on a VWR-Hitachi system equipped with an L-2300 pump, an L-2200 autosampler, an L-2300 column oven (24 °C), an L-2455 Diode Array Detector (DAD) and a LiChroCart TM column (4 x 125 mm) containing reversed phase silica gel Purospher TM RP18e (5 μm) purchased from VWR. Detailed methods for analytical HPLC are given below. Preparative HPLC was carried out on a Jasco system equipped with a DG-2080-53 degasser, two PU-2080 Plus pumps, a UV-2075 Plus UV/Vis detector (detection at 260 nm) and one of the two following columns purchased from Macherey-Nagel: column I:
S2 21 x 250 mm, containing reversed phase silica gel Nucleodur 100-5 C18ec (5 μm); column II: 10 x 250 mm, containing reversed phase silica gel Nucleodur 100-5 C18ec (5 μm).
Detailed methods for preparative HPLC are given below. 300 MHz-and 600 were recorded on a Perkin-Elmer polarimeter 241 with a Na source using a 10 cm cell (concentrations in g/100 mL). Infrared spectroscopy (IR) was performed on a Perkin-Elmer Vektor 22 spectrometer with solids being measured as KBr pills or on a Jasco FT/IR-4100 spectrometer equipped with an integrated ATR unit (GladiATR , PIKE Technologies).
Wavenumbers ( ) are quoted in cm -1 . UV spectroscopy was carried out on a Perkin-Elmer Lambda 2 spectrometer. Wavelengths of maximum absorption ( max ) are reported in nm with the corresponding logarithmic molar extinction coefficient (log , /dm 3 mol -1 cm -1 ) given in parenthesis. To a solution of the thus obtained N-Cbz-protected 5'-epi-muraymycin analogue in MeOH (4 mL), Pd/C (10 %, 5 mg, 5 mol Pd) and 1,4-cyclohexadiene 15 (12 μL, 0.13 mmol) were added. The reaction mixture was stirred at r.t. for 1 h and then filtered through a syringe filter.
Methods for analytical HPLC
The syringe filter was washed with MeOH (3 x 4 mL). -4.3, -4.0, -4.0, 19.0, 19.0, 22.6, 23.5, 26.0, 26.4, 26.5, 28.6, 30.8, 38.4, 45.7, 46.6, 54.7, 65.3, 74.1, 74.3, 75.3, 82.8, 87.9, 89.6, 103.2, 143.3, 152.4, 165.7, 173.2, 177.9 . -4.0, -4.0, 18.8, 19.0, 22.6, 23.5, 26.0, 26.4, 26.50, 28.6, 30.8, 38.4, 44.6, 45.7, 46.7, 54.6, 55.7, 65.3, 74.1, 74.3, 75.4, 82.9, 88.0, 90.3, 102.8, 114.6, 130.1, 131.3, 141.5, 152.4, 160.5, 164.5, 173.2, 177.9 . Deprotected 6'-epi-muraymycin core structure 7
MS (ESI
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Protected 6'-epi azido derivative 14 (12 mg, 19 μmol) was dissolved in TFA (80 % in water, 3.0 mL), and the reaction mixture was stirred at r.t. for 24 h. Water (10 mL) was added, and the solvent was evaporated under reduced pressure. The resultant crude product was purified by preparative HPLC (method III, t R = 17.5 min) to give the deprotected 6'-epi azido derivative as a colorless solid.
To a solution of the thus obtained deprotected 6'-epi azido derivative in degassed water (4 mL), Pd/C (10 %, 5 mg, 5 mol Pd) and 1,4-cyclohexadiene 15 (18 μL, 0.19 mmol) were S8 added. The reaction mixture was stirred at r.t. for 1 h and then filtered through a syringe filter.
The syringe filter was washed with water (3 x 4 mL). The solvent of the combined filtrates was evaporated under reduced pressure to give 7 as a colorless solid. Yield: 5.5 mg (89 % over 2 steps from 14).
Mp 98 Deprotected 5'-epi-muraymycin core structure 8
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Protected 5'-epi azido derivative 20 (7.2 mg, 11 μmol) was dissolved in TFA (80 % in water, 1.7 mL), and the reaction mixture was stirred at r.t. for 24 h. Water (10 mL) was added, and the solvent was evaporated under reduced pressure. The resultant crude product was purified by preparative HPLC (method III, t R = 14.7 min) to give the deprotected 5'-epi azido derivative as a colorless solid.
To a solution of the thus obtained deprotected 5'-epi azido derivative in degassed water (4 mL), Pd/C (10 %, 5 mg, 5 mol Pd) and 1,4-cyclohexadiene 15 (10 μL, 0.11 mmol) were added. The reaction mixture was stirred at r.t. for 1 h and then filtered through a syringe filter.
The syringe filter was washed with water (3 x 4 mL). The solvent of the combined filtrates 
(5'R,6'S)-Epoxy ester 12 12
To a suspension of sulfonium salt 11 (3.75 g, 14.6 mmol) in THF (100 mL), NaH (60 % dispersion in oil, 6.42 g, 16.0 mmol) was added, and the mixture was stirred at r.t. for 3 h.
After filtration, the residue was washed with THF (2 x 50 mL) and the solvent of the combined filtrates was evaporated under reduced pressure. The resultant residue was dissolved in CH 2 Cl 2 (8 mL) and then added to a solution of protected uridine-5'-aldehyde 9 (2.29 g, 4.78 mmol) in CH 2 Cl 2 (25 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 4 h and then diluted with CH 2 Cl 2 (100 mL) and washed with water (100 mL). The aqueous layer was extracted with EtOAc (100 mL). The combined organics were dried over Na 2 SO 4
and evaporated under reduced pressure. The resultant crude product was purified by column chromatography (petroleum ether-EtOAc, 4 : 1) to give 12 as a colorless solid. Yield: 1.77 g (63 %). -4.7, -4.4, -4.31, 18.2, 18.3, 25.9, 26.0, 27.8, 51.4, 56.8, 73.4, 75.8, 78.6, 82.5, 89.4, 102.7, 138.6, 150.8, 163 .1, 167.1. (5'R,6'S)-N-3-PMB-Epoxy ester 13
MS (ESI
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A suspension of sulfonium salt 11 (430 mg, 1.67 mmol) in THF (10 mL) was stirred with freshly activated molecular sieves (4 Å) at r.t. for 2 h. NaH (60 % dispersion in oil, 68 mg, 1.7 mmol) was then added at 0 °C, and the mixture was stirred at r.t. for 4 h. After filtration, the residue was washed with THF (2 x 5 mL) and the solvent of the combined filtrates was evaporated under reduced pressure. The resultant residue was dissolved in CH 2 Cl 2 (2 mL) and then added portionwise to a solution of protected N-3-PMB-uridine-5'-aldehyde 10 (99 mg, 0.17 mmol) in CH 2 Cl 2 (2 mL) at 0 °C over 1.5 h. The reaction mixture was stirred at 0 °C for 2.5 h and then diluted with CH 2 Cl 2 (25 mL) and washed with water (25 mL). The aqueous layer was extracted with EtOAc (25 mL). The combined organics were dried over Na 2 SO 4
and evaporated under reduced pressure. The resultant crude product was purified by column S12 -4.7, -4.5, -4.5, 18.2, 18.2, 25.9, 26.0, 27.8, 43.7, 51.2, 54.6, 56.9, 73.7, 75.6, 78.9, 82.5, 89.2, 102.7, 114.0, 129.8, 131.5, 136.5, 151.4, 159.7, 161.8, 167 .1. 
MS (ESI
Protected 6'-epi azido derivative 14 14
To a solution of (5'R,6'S)-epoxy ester 12 (30 mg, 51 μmol) in DMF (3 mL), Amberlyst-15 (14 mg, 65 μmol) and tetra-n-butyl ammonium azide (48 mg, 0.17 mmol) were added and the reaction mixture was stirred at r.t. for 12 h. After filtration, the residue was washed with Et 2 O (3 x 15 mL) and the combined filtrates were washed with water (50 mL). The organic layer was dried over Na 2 SO 4 and evaporated under reduced pressure. The resultant crude product was purified by column chromatography (petroleum ether-EtOAc -4.9, -4.8, -4.6, 17.5, 17.6, 25.5, 25.6, 27.5, 63.0, 68.9, 72.6, 74.2, 82.3, 84.0, 86.8, 102.1, 139.8, 150.5, 162.6, 167 .0. -3.9, 18.3, 18.3, 26.1, 26.2, 27.9, 52.9, 56.4, 72.4, 74.6, 82.5, 83.6, 92.2, 102.5, 140.6, 150.4, 163.2, 166.9 . 
MS (ESI
(5'S,6'R)-N-3-PMB-Epoxy ester 19
19
S16
To a solution of (5'S,6'R)-epoxy ester 18 (40 mg, 68 μmol) in CH 2 Cl 2 (2 mL), tetra-n-butyl ammonium iodide (1 mg, 3 mol), PMBCl (0.5 M in CH 2 Cl 2 , 0.28 mL, 0.14 mmol) and -4.0, 18.3, 18.3, 26.1, 26.1, 28.0, 43.8, 53.1, 54.8, 56.5, 72.8, 74.4, 82.4, 84.0, 92.5, 102.4, 114.0, 129.8, 131.4, 138.5, 151.1, 159.6, 161.8, 166 .9. 
MS (ESI
Protected 5'-epi azido derivative 20 20
To a solution of (5'S,6'R)-epoxy ester 18 (12 mg, 21 μmol) in DMF (3 mL), Amberlyst-15 (6.8 mg, 32 μmol) and tetra-n-butyl ammonium azide (24 mg, 84 μmol) were added and the reaction mixture was stirred at r.t. for 16 h. After filtration, the residue was washed with Et 2 O (3 x 15 mL) and the combined filtrates were washed with water (3 x 30 mL). -4.7, -4.7, -4.7, 17.5, 17.7, 20.7, 22.8, 24.2, 25.5, 25.6, 27.7, 29.8, 36.3, 39.9, 44.8, 53.1, 63.6, 65.2, 70.6, 73.5, 74.4, 79.9, 85.1, 86.2, 102.1, 127.4, 127.5, 128.0, 136.9, 140.2, 150.6, 155.6, 162.6, 171.7, 172.9 . -4.7, -4.7, -4.5, -4.3, 18.2, 18.2, 21.5, 23.5, 25.0, 26.1, 26.1, 28.1, 30.1, 35.7, 43.6, 44.5, 45.3, 53.6, 54.7, 65.3, 69.8, 73.1, 74.7, 81.4, 85.4, 92.4, 102.1, 114.0, 129.8, 131.5, 139.8, 151.4, 159.6, 162.3, 172.5, 175.4 . 8, 24.2, 26.6, 27.9, 39.0, 42.5, 47.8, 54.7, 66.1, 71.9, 73.4, 74.5, 85.9, 93.9, 104.9, 118.9 
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Stereochemical assignments of target structures
The stereochemical assignments of all epimeric muraymycin analogues prepared in this study is based on two rationales: (i) the stereochemical configuration of the trans-epoxide intermediates 12,13 and 18,19 and (ii) the S N 2-type nature of the regioselective epoxide ringopening reactions.
The trans-configuration of the epoxides 12,13 and 18,19 was readily proven by the small values of the 1 H NMR 3 J coupling constants of the oxirane ring protons (5'-H and 6'-H).
However, the configuration of the newly formed stereocenters at C-5' and C-6' in epoxides 12
and 13 (obtained via sulfur ylide reactions) had led to some initial confusion as explained in note 11 of the main paper. Based on X-ray crystallography, the configuration of the epoxide stereocenters in 12 and 13 could then be determined unambiguously, S3 and this finding was later confirmed by additional investigations. S6 The configuration of the epoxide stereocenters in 18 and 19 (obtained via Sharpless epoxidation) could be determined unambiguously based on the chosen DET ligand for the epoxidation reaction and the non-identity of one of the thus furnished epoxides with a corresponding product obtained via the sulfur ylide route.
S6
The S N 2-type and regioselective nature of ring-opening reactions of uridine-derived epoxides with nitrogen nucleophiles via nucleophilic attack at the C-6' position has been reported before. S1-S3,S5,S6 All experimental observations made within this study fully match these previous findings: the epoxide-opening reactions exclusively furnished one diastereomer only in all cases, thus indicating a stereospecific S N 2-type process. The selective epoxide-opening via nucleophilic attack at the C-6' position was proven by rigorous NMR analyses. The epoxide-opening reactions exclusively furnished one regioisomer only in all cases.
In addition to this rationalization, the non-identity of the obtained epimeric muraymycin analogues with each other was proven by NMR spectroscopy. Furthermore, azido alcohol key intermediates 14 (6'-epimer) and 20 (5'-epimer) were spectroscopically found to be non-
S28
identical with the corresponding (5'S,6'S)-azido alcohol having the stereochemical configuration of naturally occurring muraymycins. The synthesis of the latter compound has been performed in our laboratories and will be reported elsewhere in due course. 
